Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're on other medicines and considering tirzepatide, the question of drug interactions is a reasonable one to raise before you start. Mounjaro slows gastric emptying, which changes the rate at which your gut absorbs other medicines — and that single mechanism has ripple effects worth understanding. As a prescription-only treatment, it's assessed by a prescriber who reviews your full medication list before anything is approved. This page covers what the evidence currently shows, clearly and without alarm.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: you've been managing a long-term condition for years, you take your medicines every morning on a schedule, and now you're weighing up whether tirzepatide fits alongside them. The worry is understandable, and it's exactly the kind of thing our prescribers work through with patients regularly.
The core issue is this: Mounjaro slows gastric emptying. Food, fluid and oral medicines all move through the stomach more slowly than usual. For most drugs this change is modest and clinically unimportant. For a handful, the timing and extent of absorption matters enough to warrant attention. The full picture of Mounjaro's interaction profile is detailed elsewhere, but the key categories are worth naming here.
Oral medicines with a narrow therapeutic window (meaning there's a small gap between the dose that works and the dose that causes problems) are the ones prescribers watch most carefully. Warfarin (a blood thinner) is a classic example; its effect is measured by INR, and any factor that changes absorption timing can shift that reading. If you're on warfarin, more frequent INR monitoring when starting tirzepatide is standard clinical practice. The same principle applies to certain thyroid medicines taken on an empty stomach, where even a small absorption change can affect how well the dose works. If you want a comprehensive overview of what medicines interact with Mounjaro, including which combinations need the closest monitoring, that resource covers the topic in detail. These aren't reasons to avoid treatment, they're reasons to flag the medicines you take so your prescriber can plan accordingly.
This interaction gets its own section because it's one of the few where there's specific MHRA guidance, and because it matters practically for a large number of people starting treatment.
When tirzepatide slows gastric emptying, the contraceptive pill may be absorbed less consistently, particularly in the first weeks of treatment and after each dose increase. The MHRA advises that anyone using oral hormonal contraception should add a non-oral method (condoms being the most straightforward) for the first four weeks on tirzepatide and for four weeks after any dose step up. This guidance applies specifically to tirzepatide; current evidence doesn't point to the same concern for injectable semaglutide (Wegovy). You can read more about tirzepatide's specific interaction list if you want the fuller clinical picture.
HRT is a related question. NHS England advises that anyone on oral HRT while starting tirzepatide should consider switching to a transdermal form (patches or gels) for the same absorption reason. This is a conversation to have with your GP or prescriber before treatment begins, not something to change unilaterally. The NHS England guidance on weight-management injections sets this out in plain terms.
Mounjaro is itself licensed for type 2 diabetes as well as weight management, and it lowers blood glucose effectively. That's useful if you have diabetes, but it also means that combining it with insulin or a sulfonylurea (such as gliclazide or glipizide) can push blood sugar lower than intended.
This isn't a reason to avoid the combination. It's a reason to have your diabetes medicines reviewed before starting tirzepatide, so doses can be adjusted. Prescribers at a service like clinician-led platforms will ask about your diabetes medicines specifically, and in some cases will want to liaise with your GP or diabetes team. People with well-controlled type 2 diabetes often do very well on tirzepatide, the interaction is manageable when it's planned for.
If you're curious about how tirzepatide works as a medicine, the overview of tirzepatide covers its dual GIP and GLP-1 mechanism in more depth.
For most people, the majority of their regular medicines sit outside the categories above, and the interaction risk is low. Antihypertensives, statins, most antidepressants and standard pain relief don't have well-documented clinically significant interactions with tirzepatide. That said, the honest answer is that tirzepatide is relatively new, and post-marketing data continues to accumulate. The MHRA's Yellow Card scheme exists precisely so that unexpected reactions get reported and the picture stays current.
Practically speaking, the most useful thing you can do before any consultation is write down everything you take: prescription medicines, over-the-counter items, vitamins, supplements. Bring the lot. A prescriber can only assess what they know about. Some interactions between herbal supplements (St John's Wort being the most cited example) and medicines that affect absorption are well established, your prescriber will want to know.
If you're managing the balance of electrolytes and nutrition alongside treatment (something that comes up when appetite falls significantly) there's useful reading in our piece on electrolytes and Mounjaro. Cost is sometimes a factor in treatment decisions too; the context around Mounjaro's UK pricing is worth understanding before you plan. When you're ready to have all of this reviewed by a prescriber who will look at your full medication history, you can start your free consultation with nume, the process is straightforward, and there's no obligation until treatment is agreed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.